Evidence map›Paper›PMID 26367260›Full record

ArticlePloS one2015

In Vitro and In Vivo Studies on Protective Action of N-Phenethyl Caffeamide against Photodamage of Skin.

Yueh-Hsiung Kuo, Chien-Wen Chen, Yin Chu, Ping Lin, Hsiu-Mei Chiang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Skin Aging: Insights into the Role of Fatty Acids.Current pharmaceutical design · 2025
    Review
  3. Review
  4. Laricitrin 3-Rutinoside fromAntioxidants (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Protective Effects and Mechanisms ofInternational journal of molecular sciences · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. N-(4-methoxyphenyl) caffeamide-induced melanogenesis inhibition mechanisms.BMC complementary and alternative medicine · 2017
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yueh-Hsiung KuoDepartment of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan; Department of Biotechnology, Asia University, Taichung 413, Taiwan.
Chien-Wen ChenDepartment of Cosmeceutics, China Medical University, Taichung 404, Taiwan.
Yin ChuDepartment of Cosmeceutics, China Medical University, Taichung 404, Taiwan.
Ping LinDepartment of Cosmeceutics, China Medical University, Taichung 404, Taiwan.
Hsiu-Mei ChiangDepartment of Cosmeceutics, China Medical University, Taichung 404, Taiwan.
China Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In our previous study, N-phenethyl caffeamide (K36) was proved to act as an antioxidant and an antiphotoaging agent by inhibiting type I procollagen degradation and stimulating collagen synthesis in human skin fibroblasts. In the present study, in vitro and in vivo experiments were conducted to investigate the mechanism of action and the antiinflammatory and antiphotoaging activity of K36. K36 reduced UVB-induced cyclooxygenase-2 (COX-2) and inducible nitric oxide synthases (iNOS) expression by regulating IκB and p-IκB expression. K36 also inhibited the nuclear translocation of NF-κB. Furthermore, the inhibition of mitogen-activated protein (MAP) kinases by K36 was attributed to the downregulation of COX-2. Topically applying K36 led to efficient antiwrinkle formation and reduced UVB-induced erythema and thickness of epidermis in hairless mice. In addition, K36 penetrated into the skin of hairless mice. Our findings show that K36 has significant beneficial effects on antioxidant, antiinflammatory, and antiphotoaging activity and suggest that K36 can be developed as an antiaging agent for cosmetic and skin care products.

Indexed as

AnimalsCaffeic AcidsCell LineCyclooxygenase 2EpidermisHumansI-kappa B ProteinsMiceNF-kappa BNitric Oxide Synthase Type IISkin AgingSunscreening AgentsUltraviolet RaysCaffeic AcidsCyclooxygenase 2I-kappa B ProteinsN-2-(4-bromophenyl) ethyl caffeamideNF-kappa BNitric Oxide Synthase Type IIN-phenethyl caffeamideSunscreening Agents

Identifiers

PMID26367260
PMCPMC4569286
OpenAlexW2216427538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.